Loading clinical trials...
Loading clinical trials...
A Phase III, 18-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata
Conditions
Interventions
Asoprisnil
Asoprisnil
Start Date
April 1, 2004
Primary Completion Date
December 1, 2006
Completion Date
December 1, 2006
Last Updated
May 29, 2008
NCT00050752
NCT06538454
NCT06405997
NCT07474688
NCT01552434
NCT05607602
Lead Sponsor
Abbott
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions